211 related articles for article (PubMed ID: 18842708)
61. Retention of oncogenicity by a Marek's disease virus mutant lacking six unique short region genes.
Parcells MS; Anderson AS; Morgan TW
J Virol; 1995 Dec; 69(12):7888-98. PubMed ID: 7494301
[TBL] [Abstract][Full Text] [Related]
62. [Cloning and sequence analysis of the Meq gene of 4 Marek's disease virus isolates from China].
Shi WS; Liu CJ; Zhang YP; Qin YA; Zhang XW; Li JM; Chen HY
Bing Du Xue Bao; 2008 Jun; 24(2):117-25. PubMed ID: 18533343
[TBL] [Abstract][Full Text] [Related]
63. Properties of a meq-deleted rmd5 Marek's disease vaccine: protection against virulent MDV challenge and induction of lymphoid organ atrophy are simultaneously attenuated by serial passage in vitro.
Lee LF; Kreager K; Heidari M; Zhang H; Lupiani B; Reddy SM; Fadly A
Avian Dis; 2013 Jun; 57(2 Suppl):491-7. PubMed ID: 23901766
[TBL] [Abstract][Full Text] [Related]
64. Isolation and pathogenic analysis of virulent Marek's disease virus field strain in China.
Cui N; Su S; Sun P; Zhang Y; Han N; Cui Z
Poult Sci; 2016 Jul; 95(7):1521-1528. PubMed ID: 26976907
[TBL] [Abstract][Full Text] [Related]
65. Real-time PCR for differential quantification of CVI988 vaccine virus and virulent strains of Marek's disease virus.
Baigent SJ; Nair VK; Le Galludec H
J Virol Methods; 2016 Jul; 233():23-36. PubMed ID: 26973285
[TBL] [Abstract][Full Text] [Related]
66. Artificially inserting a reticuloendotheliosis virus long terminal repeat into a bacterial artificial chromosome clone of Marek's disease virus (MDV) alters expression of nearby MDV genes.
Kim T; Mays J; Fadly A; Silva RF
Virus Genes; 2011 Jun; 42(3):369-76. PubMed ID: 21340512
[TBL] [Abstract][Full Text] [Related]
67. Molecular characterization and phylogenetic analysis of Marek's disease virus from clinical cases of Marek's disease in Egypt.
Hassanin O; Abdallah F; El-Araby IE
Avian Dis; 2013 Jun; 57(2 Suppl):555-61. PubMed ID: 23901775
[TBL] [Abstract][Full Text] [Related]
68. Marek's disease virus-encoded analog of microRNA-155 activates the oncogene c-Myc by targeting LTBP1 and suppressing the TGF-β signaling pathway.
Chi JQ; Teng M; Yu ZH; Xu H; Su JW; Zhao P; Xing GX; Liang HD; Deng RG; Qu LH; Zhang GP; Luo J
Virology; 2015 Feb; 476():72-84. PubMed ID: 25528440
[TBL] [Abstract][Full Text] [Related]
69. Detection of the meq gene in the T cell subsets from chickens infected with Marek's disease virus serotype 1.
Chang KS; Ohashi K; Lee SI; Takagi M; Onum M
Jpn J Vet Res; 2005 Aug; 53(1-2):3-11. PubMed ID: 16190317
[TBL] [Abstract][Full Text] [Related]
70. Small RNA cloning and sequencing strategy affects host and viral microRNA expression signatures.
Stik G; Muylkens B; Coupeau D; Laurent S; Dambrine G; Messmer M; Chane-Woon-Ming B; Pfeffer S; Rasschaert D
J Biotechnol; 2014 Jul; 181():35-44. PubMed ID: 24746587
[TBL] [Abstract][Full Text] [Related]
71. Analysis of the expression profiles of Marek's disease virus-encoded microRNAs by real-time quantitative PCR.
Xu H; Yao Y; Zhao Y; Smith LP; Baigent SJ; Nair V
J Virol Methods; 2008 May; 149(2):201-8. PubMed ID: 18355930
[TBL] [Abstract][Full Text] [Related]
72. Research Note: Characterization of S-Meq containing the deletion in Meq protein's transactivation domain in a Marek's disease virus strain in Japan.
Murata S; Yamamoto E; Sakashita N; Maekawa N; Okagawa T; Konnai S; Ohashi K
Poult Sci; 2021 Nov; 100(11):101461. PubMed ID: 34601441
[TBL] [Abstract][Full Text] [Related]
73. First report of Serotype-1 Marek's disease virus (MDV-1) with oncogenic form in backyard turkeys in Turkey: a molecular analysis study.
Ongor H; Timurkaan N; Abayli H; Karabulut B; Kalender H; Tonbak S; Eroksuz H; Çetinkaya B
BMC Vet Res; 2022 Jan; 18(1):30. PubMed ID: 35016700
[TBL] [Abstract][Full Text] [Related]
74. Characterizing the molecular basis of attenuation of Marek's disease virus via in vitro serial passage identifies de novo mutations in the helicase-primase subunit gene UL5 and other candidates associated with reduced virulence.
Hildebrandt E; Dunn JR; Perumbakkam S; Niikura M; Cheng HH
J Virol; 2014 Jun; 88(11):6232-42. PubMed ID: 24648463
[TBL] [Abstract][Full Text] [Related]
75. In vitro characterization of the Meq proteins of Marek's disease virus vaccine strain CVI988.
Ajithdoss DK; Reddy SM; Suchodolski PF; Lee LF; Kung HJ; Lupiani B
Virus Res; 2009 Jun; 142(1-2):57-67. PubMed ID: 19189855
[TBL] [Abstract][Full Text] [Related]
76. gga-miR-26a targets NEK6 and suppresses Marek's disease lymphoma cell proliferation.
Li X; Lian L; Zhang D; Qu L; Yang N
Poult Sci; 2014 May; 93(5):1097-105. PubMed ID: 24795301
[TBL] [Abstract][Full Text] [Related]
77. Unraveling the role of B cells in the pathogenesis of an oncogenic avian herpesvirus.
Bertzbach LD; Laparidou M; Härtle S; Etches RJ; Kaspers B; Schusser B; Kaufer BB
Proc Natl Acad Sci U S A; 2018 Nov; 115(45):11603-11607. PubMed ID: 30337483
[TBL] [Abstract][Full Text] [Related]
78. Marek's disease virus EcoRI-Q gene (meq) and a small RNA antisense to ICP4 are abundantly expressed in CD4+ cells and cells carrying a novel lymphoid marker, AV37, in Marek's disease lymphomas.
Ross N; O'Sullivan G; Rothwell C; Smith G; Burgess SC; Rennie M; Lee LF; Davison TF
J Gen Virol; 1997 Sep; 78 ( Pt 9)():2191-8. PubMed ID: 9292006
[TBL] [Abstract][Full Text] [Related]
79. Fluorescently tagged pUL47 of Marek's disease virus reveals differential tissue expression of the tegument protein in vivo.
Jarosinski KW; Arndt S; Kaufer BB; Osterrieder N
J Virol; 2012 Mar; 86(5):2428-36. PubMed ID: 22190714
[TBL] [Abstract][Full Text] [Related]
80. Activation of Toll-like receptor 3 inhibits Marek's disease virus infection in chicken embryo fibroblast cells.
Hu X; Zou H; Qin A; Qian K; Shao H; Ye J
Arch Virol; 2016 Mar; 161(3):521-8. PubMed ID: 26597188
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]